[Federal Register Volume 86, Number 115 (Thursday, June 17, 2021)]
[Notices]
[Pages 32247-32248]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12808]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-12-2021]


Foreign-Trade Zone (FTZ) 5--Seattle, Washington; Authorization of 
Production Activity; Juno Therapeutics, Inc. (Biopharmaceuticals), 
Bothell, Washington

    On February 12, 2021, Juno Therapeutics, Inc., submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within Subzone 5C, in Bothell, Washington.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (86 FR 11921, March 1,

[[Page 32248]]

2021). On June 14, 2021, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including Section 400.14.

    Dated: June 14, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-12808 Filed 6-16-21; 8:45 am]
BILLING CODE 3510-DS-P